Translational research with pemetrexed in breast cancer.

Abstract

Pemetrexed (Alimta) is a novel folate antimetabolite that primarily inhibits the enzymes thymidylate synthase (TS), dihydrofolate reductase (DHFR), and glycinamide ribonucleotide formyl transferase (GARFT), all of which are involved in pyrimidine and purine synthesis. In a phase II trial of patients with T3/4, N0-2 breast cancer, expression of thymidylate synthase (TS), dihydrofolate reductase (DHFR), glycinamide ribonucleotide formyltransferase (GARFT), p53, and c-erb-B2 (at the mRNA or protein level) was examined in tumor biopsy specimens before and 24 hours after the first dose of pemetrexed and after three cycles of single-agent treatment to establish correlations of biomarker levels and changes with clinical outcome and toxicity. Although final data are not available, initial indications are that clinical response may correlate with decreased or low TS expression. The results obtained from clinical data are supported by laboratory results in three cell lines (MDA-231, MCF-7, and ZR-75). These results suggest that in vitro transcript profiling to identify which genes are important predictors of successful cytotoxic chemotherapy, followed by a focused clinical trial to confirm the in vitro results, may be the best approach for translational research.

• Authors: Axel R Hanauske
• Journal: Oncology (Williston Park, N.Y.) (Oncology (Williston Park)) Vol. 18 Issue 13 Suppl 8 Pg. 66-9 (Nov 2004) ISSN: 0890-9091 [Print] United States
• PMID: 15655941 (Publication Type: Journal Article, Review)

Chemical References

• Folic Acid Antagonists
• Glutamates
• RNA, Messenger
• Pemetrexed
• Guanine
• Thymidylate Synthase

Topics

• Breast Neoplasms (drug therapy, genetics, pathology)
• Clinical Trials, Phase II as Topic
• Female
• Folic Acid Antagonists (administration & dosage)
• Gene Expression Regulation, Neoplastic
• Glutamates (administration & dosage)
• Guanine (administration & dosage, analogs & derivatives)
• Humans
• Pemetrexed
• Protein Biosynthesis
• RNA, Messenger (analysis)
• Thymidylate Synthase (antagonists & inhibitors)